Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Now, a new vaccine designed to train the body’s immune system to attack this rogue protein is showing promise in early trials ...

Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies ...

Exercise seems to help prevent cancer and reduce the growth of tumours, and that protective effect may be due to the way ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Overall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...

Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.

Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...

Some treatments for rheumatoid arthritis could increase cancer risk. One reason is because some cells in our immune system ...